CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

ProFound Therapeutics Receives Investment to Tackle Preeclampsia and Eclampsia

Positive
AI Analysis

Summary

ProFound Therapeutics receives up to $35 million in funding from the Gates Foundation to develop new drug targets and biomarkers for preeclampsia and eclampsia using its platform technology and algorithms.

Importance:5/10
Sentiment:
0.70
investmentpreeclampsiaeclampsiadrug discoverybiomarkersplatform technology

Read the original article

Published by PR Newswire Biotech on August 27, 2026 10:30 AM

Read Original